Health
BioNTech/Pfizer vaccine found effective against Covid-19 variant – Financial Times
Laboratory-based study shows mutations were neutralised by antibodies in blood of vaccinated patients
The Covid-19 vaccine developed by BioNTech and Pfizer is likely to be effective against a rapidly spreading strain of the virus that was first discovered in the UK, a laboratory-based study by the companies has shown.
The variant, known as B.1.1.7, has a high number of mutations, which has led to concerns that could bypass the immune defences built up by vaccines being rolled out worldwide, a large proportion of which have been made by BioNTech and Pfizer.
However, researchers at BioNTech’s headquarters…
-
Business22 hours agoA key reason why many ASX fund managers underperformed last financial year
-
Business18 hours agoWhat could happen to the big 4 banks in FY26?
-
Noosa News21 hours ago2025’s Melbourne International Film Festival Is Opening with the Rose Byrne-Starring ‘If I Had Legs I’d Kick You’
-
Noosa News22 hours agoCharity gala funds 18 vital pieces of peadiatric medical equipment